Nurix Therapeutics (NRIX) Interest & Investment Income (2019 - 2026)
Nurix Therapeutics (NRIX) posted Interest & Investment Income of $3.96 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), down 20.2% from $4.96 million a year earlier and down 9.9% from the prior quarter.
Nurix Therapeutics (NRIX) Interest & Investment Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Aug 31, 2026, Interest & Investment Income at Nurix Therapeutics was $18.56 million, down 20.1% year-over-year; for FY2025 (ended Nov 30, 2025), it was $21.97 million, up 11.4% from FY2024.
- Annual Interest & Investment Income has increased for four consecutive fiscal years, with a five-year compound annual growth rate of 78.7% (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' Interest & Investment Income was $19.73 million in FY2024 (+77.5%), $11.12 million in FY2023 (+216.9%), $3.51 million in FY2022 (+326.1%) and $823,000 in FY2021 (-31.8%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Interest & Investment Income since fiscal Q1 2024.
- On a year-over-year basis, Interest & Investment Income has declined in each of the last five quarters, with growth averaging 12.1% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was fiscal Q1 2023, with growth of 951.7%; the weakest was fiscal Q1 2022, with a decline of 33.6%.
- According to Business Quant data, Interest & Investment Income for the three prior fiscal quarters was $4.4 million (Q2 2026), $5.32 million (Q1 2026) and $4.87 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 3.96 Mn |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 3.96 Mn |
| May 31, 2026 | 4.40 Mn |
| Feb 28, 2026 | 5.32 Mn |
| Nov 30, 2025 | 4.87 Mn |
| Aug 31, 2025 | 4.96 Mn |
| May 31, 2025 | 5.62 Mn |
| Feb 28, 2025 | 6.51 Mn |
| Nov 30, 2024 | 6.12 Mn |
| Aug 31, 2024 | 5.74 Mn |
| May 31, 2024 | 4.08 Mn |
| Feb 29, 2024 | 3.79 Mn |
| Nov 30, 2023 | 3.38 Mn |
| Aug 31, 2023 | 3.03 Mn |
| May 31, 2023 | 2.49 Mn |
| Feb 28, 2023 | 2.22 Mn |
| Nov 30, 2022 | 1.97 Mn |
| Aug 31, 2022 | 1.01 Mn |
| May 31, 2022 | 314,000.00 |
| Feb 28, 2022 | 211,000.00 |
| Nov 30, 2021 | 295,000.00 |
Nurix Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();